Advanced Solid Malignancies Completed Phase 1 Trials for Topotecan (DB01030)

Also known as: Advanced Solid Malignancy

IndicationStatusPhase
DBCOND0034803 (Advanced Solid Malignancies)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00295243Phase I Study of GW572016 With Topotecan to Treat Advanced Solid MalignanciesTreatment